Dorzolamide
- Level
- Commodity
- Parent
- 51241100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51241107This classification denotes a carbonic anhydrase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9JDX055TW1. European Medicines Agency schedules Dorzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06374MIG. Dorzolamide generally arises in the molecular formula C10H16N2O4S3. The term DORZOLAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33.) DORZOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dorzolamide under HS 29350090 and SITC 51580. As of Q4 2014, DORZOLAMIDE remains the US FDA Preferred Term for this commodity. Dorzolamide bears US NLM identifiers UMLS ID C0165590 and NCI Concept Code C62026. SMILES: CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.
Same parent
Under 51241100 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51240000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.